Advancing Cancer Care Through Research – Alexander I. Spira MD, PhD, FACP, FASCO

Watch Alex Spira, MD, PhD, FACP, FASCO discuss findings from a global Phase I study evaluating an investigational therapy for previously treated patients with EGFR-mutated non-small cell lung cancer, presented at the IASLC World Conference on Lung Cancer. Link — Metastatic EGFR-Mutated NSCLC Global Study of Izalontamab Brenitecan – The ASCO Post